These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 27492867)

  • 21. Comparison of the survival and tolerability of radioembolization in elderly vs. younger patients with unresectable hepatocellular carcinoma.
    Golfieri R; Bilbao JI; Carpanese L; Cianni R; Gasparini D; Ezziddin S; Paprottka PM; Fiore F; Cappelli A; Rodriguez M; Ettorre GM; Saltarelli A; Geatti O; Ahmadzadehfar H; Haug AR; Izzo F; Giampalma E; Sangro B; Pizzi G; Notarianni E; Vit A; Wilhelm K; Jakobs TF; Lastoria S;
    J Hepatol; 2013 Oct; 59(4):753-61. PubMed ID: 23707371
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Right gastric artery embolization prior to treatment with yttrium-90 microspheres.
    Cosin O; Bilbao JI; Alvarez S; de Luis E; Alonso A; Martinez-Cuesta A
    Cardiovasc Intervent Radiol; 2007; 30(1):98-103. PubMed ID: 17031727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Novel Endoscopic Bariatric Procedure: Results of an Experimental Study.
    Kipshidze N; Prakash A; Kipshidze N; Chakhunashvili D; Kakabadze Z
    Obes Surg; 2016 Dec; 26(12):3058-3065. PubMed ID: 27718177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Yttrium-90 Radioembolization as a Salvage Treatment following Chemoembolization for Hepatocellular Carcinoma.
    Johnson GE; Monsky WL; Valji K; Hippe DS; Padia SA
    J Vasc Interv Radiol; 2016 Aug; 27(8):1123-9. PubMed ID: 27321889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical Safety of Bariatric Arterial Embolization: Preliminary Results of the BEAT Obesity Trial.
    Weiss CR; Akinwande O; Paudel K; Cheskin LJ; Holly B; Hong K; Fischman AM; Patel RS; Shin EJ; Steele KE; Moran TH; Kaiser K; Park A; Shade DM; Kraitchman DL; Arepally A
    Radiology; 2017 May; 283(2):598-608. PubMed ID: 28195823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histopathologic and immunohistochemical sequelae of bariatric embolization in a porcine model.
    Paxton BE; Alley CL; Crow JH; Burchette J; Weiss CR; Kraitchman DL; Arepally A; Kim CY
    J Vasc Interv Radiol; 2014 Mar; 25(3):455-61. PubMed ID: 24462005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Balancing Safety and Efficacy to Determine the Most Suitable Size of Imaging-Visible Embolic Microspheres for Bariatric Arterial Embolization in a Preclinical Model.
    Fu Y; Abiola G; Tunacao J; Vairavamurthy JP; Nwoke F; Dreher M; Shin EJ; Anders RA; Kraitchman DL; Weiss CR
    J Vasc Interv Radiol; 2023 Dec; 34(12):2224-2232.e3. PubMed ID: 37684003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bariatric Left Gastric Artery Embolization for the Treatment of Obesity: A Review of Gut Hormone Involvement in Energy Homeostasis.
    Anton K; Rahman T; Bhanushali A; Patel AA
    AJR Am J Roentgenol; 2016 Jan; 206(1):202-10. PubMed ID: 26700353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Catheter-directed gastric artery chemical embolization suppresses systemic ghrelin levels in porcine model.
    Arepally A; Barnett BP; Patel TH; Howland V; Boston RC; Kraitchman DL; Malayeri AA
    Radiology; 2008 Oct; 249(1):127-33. PubMed ID: 18796671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Science to practice: can transarterial embolotherapy be used as a viable alternative to treat obesity?
    Madoff DC
    Radiology; 2013 Feb; 266(2):369-71. PubMed ID: 23362091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microsphere localization and dose quantification using positron emission tomography/CT following hepatic intraarterial radioembolization with yttrium-90 in patients with advanced hepatocellular carcinoma.
    Lea WB; Tapp KN; Tann M; Hutchins GD; Fletcher JW; Johnson MS
    J Vasc Interv Radiol; 2014 Oct; 25(10):1595-603. PubMed ID: 25156647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bariatric Embolization in the Treatment of Patients with a Body Mass Index Between 30 and 39.9 kg/m
    Levigard RB; Serrão H; Castro C; Matos P; Mattos F; Madeira E; Rosseti CL; de Carvalho DP; Dantas JR; Zajdenverg L; Madeira M
    Cardiovasc Intervent Radiol; 2021 Apr; 44(4):598-606. PubMed ID: 33527186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Catheter-directed gastric artery chemical embolization for modulation of systemic ghrelin levels in a porcine model: initial experience.
    Arepally A; Barnett BP; Montgomery E; Patel TH
    Radiology; 2007 Jul; 244(1):138-43. PubMed ID: 17581899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gastric supply manipulation to modulate ghrelin production and enhance vascularization to the cardia: proof of the concept in a porcine model.
    Diana M; Halvax P; Pop R; Schlagowski I; Bour G; Liu YY; Legner A; Diemunsch P; Geny B; Dallemagne B; Beaujeux R; Demartines N; Marescaux J
    Surg Innov; 2015 Feb; 22(1):5-14. PubMed ID: 25294792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A simple method for estimating dose delivered to hepatocellular carcinoma after yttrium-90 glass-based radioembolization therapy: preliminary results of a proof of concept study.
    Kokabi N; Galt JR; Xing M; Camacho JC; Barron BJ; Schuster DM; Kim HS
    J Vasc Interv Radiol; 2014 Feb; 25(2):277-87. PubMed ID: 24461133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiation emission from patients treated with selective hepatic radioembolization using yttrium-90 microspheres: are contact restrictions necessary?
    McCann JW; Larkin AM; Martino LJ; Eschelman DJ; Gonsalves CF; Brown DB
    J Vasc Interv Radiol; 2012 May; 23(5):661-7. PubMed ID: 22440592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transradial left gastric artery embolization to treat severe obesity: A pilot study.
    Pirlet C; Ruzsa Z; Costerousse O; Nemes B; Merkely B; Poirier P; Bertrand OF
    Catheter Cardiovasc Interv; 2019 Feb; 93(3):365-370. PubMed ID: 30286527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toxicities after radioembolization with yttrium-90 SIR-spheres: incidence and contributing risk factors at a single center.
    Piana PM; Gonsalves CF; Sato T; Anne PR; McCann JW; Bar Ad V; Eschelman DJ; Parker L; Doyle LA; Brown DB
    J Vasc Interv Radiol; 2011 Oct; 22(10):1373-9. PubMed ID: 21764600
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 90Y radioembolization versus chemoembolization in the treatment of hepatocellular carcinoma: an analysis of comparative effectiveness.
    Xing M; Kokabi N; Camacho JC; Kooby DA; El-Rayes BF; Kim HS
    J Comp Eff Res; 2013 Jul; 2(4):435-44. PubMed ID: 24236684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A descriptive analysis of remnant activity during (90)Y resin microspheres radioembolization of hepatic tumors: technical factors and dosimetric implications.
    Rodríguez LS; Thang SP; Li H; Khor LK; Tay YS; Myint KO; Tong AK
    Ann Nucl Med; 2016 Apr; 30(3):255-61. PubMed ID: 26692012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.